5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 24.12▼ | 24.08▲ | 24.10▲ | 24.12▼ | 23.84▲ |
MA10 | 24.08▲ | 24.12▼ | 24.13▼ | 24.00▲ | 23.54▲ |
MA20 | 24.13▼ | 24.09▲ | 24.09▲ | 23.86▲ | 23.02▲ |
MA50 | 24.10▲ | 23.95▲ | 23.92▲ | 23.50▲ | 22.65▲ |
MA100 | 23.95▲ | 23.82▲ | 23.74▲ | 22.90▲ | 22.30▲ |
MA200 | 23.74▲ | 23.53▲ | 23.49▲ | 22.59▲ | 22.83▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.010▼ | -0.013▼ | 0.012▲ | 0.114▲ |
RSI | 51.138▲ | 54.543▲ | 55.956▲ | 63.905▲ | 73.010▲ |
STOCH | 57.315 | 34.295 | 56.731 | 88.089▲ | 89.689▲ |
WILL %R | -46.154 | -46.154 | -46.154 | -19.403▲ | -6.012▲ |
CCI | -7.883 | 8.132 | 12.081 | 73.805 | 147.490▲ |
Thursday, July 03, 2025 06:08 AM
Pacific Biosciences of California (NASDAQ:PACB) ranks among the best CRISPR stocks to buy. Speaking on its strategic developments and challenges, Pacific Biosciences of California (NASDAQ:PACB) ...
|
Wednesday, July 02, 2025 05:05 AM
Key Insights The projected fair value for Pacific Biosciences of California is US$2.00 based on 2 Stage Free Cash ...
|
Sunday, June 08, 2025 12:09 PM
PacBio (NASDAQ:PACB) Pioneering what scientists call "HiFi long-read sequencing," recognized as Nature Methods' method of the year for 2022, Pacific Biosciences (NASDAQ:PACB) ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 24.02 | 24.14 | 24.02 | 24.11 | 21,395 |
02/07/25 | 24.04 | 24.0867 | 23.9691 | 24.08 | 62,981 |
01/07/25 | 24.24 | 24.24 | 24.18 | 24.24 | 58,600 |
30/06/25 | 24.06 | 24.18 | 24.0599 | 24.18 | 45,135 |
27/06/25 | 24.09 | 24.09 | 23.96 | 24.01 | 40,500 |
26/06/25 | 24.08 | 24.12 | 24.0413 | 24.075 | 34,721 |
25/06/25 | 23.84 | 23.95 | 23.83 | 23.95 | 74,000 |
24/06/25 | 23.80 | 23.94 | 23.77 | 23.905 | 70,287 |
23/06/25 | 23.57 | 23.77 | 23.57 | 23.755 | 28,999 |
20/06/25 | 23.74 | 23.75 | 23.69 | 23.71 | 67,600 |
|
|
||||
|
|
||||
|
|